Calliditas Therapeutics Ab ADR (CALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 74,466 | 77,872 | 91,823 | 72,787 | 82,287 |
| Receivables | 20,790 | 17,569 | 17,058 | 12,074 | 13,905 |
| Inventories | 3,751 | 2,816 | 1,926 | 1,481 | 1,681 |
| Other current assets | 0 | 0 | 1,488 | 0 | 0 |
| TOTAL | $107,827 | $105,605 | $120,247 | $95,831 | $105,791 |
| Non-Current Assets | |||||
| PPE Net | 1,558 | 1,768 | 1,514 | 1,430 | 876 |
| Investments And Advances | 2,541 | 2,412 | 2,282 | 1,930 | 1,579 |
| Intangibles | 44,054 | 45,366 | 45,202 | 44,077 | 48,928 |
| Other Non-Current Assets | 7,208 | 7,094 | 6,082 | 5,832 | 5,196 |
| TOTAL | $55,362 | $56,641 | $55,080 | $53,269 | $56,578 |
| Total Assets | $163,189 | $162,245 | $175,327 | $149,100 | $162,369 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,105 | 9,743 | 9,483 | 6,213 | 6,844 |
| Accrued Expenses | 23,550 | 26,274 | 26,463 | 23,275 | 17,815 |
| Other current liabilities | 2,486 | 3,208 | 1,866 | 2,398 | 2,921 |
| TOTAL | $40,141 | $39,225 | $38,394 | $31,886 | $27,579 |
| Non-Current Liabilities | |||||
| Long Term Debt | 91,764 | 94,792 | 88,596 | 68,519 | 72,110 |
| Other Non-Current Liabilities | 15,473 | 10,398 | 10,284 | 9,545 | 8,831 |
| TOTAL | $113,074 | $111,473 | $105,361 | $84,614 | $86,875 |
| Total Liabilities | $153,215 | $150,699 | $143,755 | $116,500 | $114,454 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | 225 | N/A | N/A |
| Retained earnings | N/A | N/A | -217,416 | N/A | N/A |
| Other shareholders' equity | 9,974 | 11,547 | -493 | 32,600 | 47,915 |
| TOTAL | $9,974 | $11,547 | $31,572 | $32,600 | $47,915 |
| Total Liabilities And Equity | $163,189 | $162,245 | $175,327 | $149,100 | $162,369 |